These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
266 related items for PubMed ID: 25727598
1. Hypersensitivity to sub-Tenon's topotecan in fibrin adhesive in patients with retinoblastoma. Astudillo PP, Durairaj P, Chan HS, Héon E, Gallie BL. J AAPOS; 2015 Feb; 19(1):86-7. PubMed ID: 25727598 [Abstract] [Full Text] [Related]
2. No ocular motility complications after subtenon topotecan with fibrin sealant for retinoblastoma. Yousef YA, Halliday W, Chan HS, Héon E, Gallie BL, Dimaras H. Can J Ophthalmol; 2013 Dec; 48(6):524-8. PubMed ID: 24314416 [Abstract] [Full Text] [Related]
3. Exudative Retinal Detachment Following Intravitreal Chemotherapeutic Treatment for Retinoblastoma. Kotlyar B, Shapiro M, Blair M. Ophthalmic Surg Lasers Imaging Retina; 2019 Apr 01; 50(4):248-252. PubMed ID: 30998248 [Abstract] [Full Text] [Related]
4. Periocular topotecan for intraocular retinoblastoma. Mallipatna AC, Dimaras H, Chan HS, Héon E, Gallie BL. Arch Ophthalmol; 2011 Jun 01; 129(6):738-45. PubMed ID: 21670340 [Abstract] [Full Text] [Related]
5. Subconjunctival topotecan in fibrin sealant in the treatment of transgenic murine retinoblastoma. Tsui JY, Dalgard C, Van Quill KR, Lee L, Grossniklaus HE, Edelhauser HF, O'Brien JM. Invest Ophthalmol Vis Sci; 2008 Feb 01; 49(2):490-6. PubMed ID: 18234990 [Abstract] [Full Text] [Related]
6. Properties and clinical utility of topotecan fluorescence: uses for retinoblastoma. Francis JH, Marr BP, Schaiquevich P, Kellick MG, Abramson DH. Br J Ophthalmol; 2015 Oct 01; 99(10):1320-2. PubMed ID: 25926516 [Abstract] [Full Text] [Related]
9. Ocular and systemic toxicity of intravitreal topotecan in rabbits for potential treatment of retinoblastoma. Buitrago E, Del Sole MJ, Torbidoni A, Fandino A, Asprea M, Croxatto JO, Chantada GL, Bramuglia GF, Schaiquevich P. Exp Eye Res; 2013 Mar 01; 108():103-9. PubMed ID: 23333535 [Abstract] [Full Text] [Related]
10. Efficacy of topotecan nanoparticles for intravitreal chemotherapy of retinoblastoma. Delrish E, Jabbarvand M, Ghassemi F, Amoli FA, Atyabi F, Lashay A, Soleimani M, Aghajanpour L, Dinarvand R. Exp Eye Res; 2021 Mar 01; 204():108423. PubMed ID: 33453276 [Abstract] [Full Text] [Related]
12. Topotecan and vincristine combination is effective against advanced bilateral intraocular retinoblastoma and has manageable toxicity. Qaddoumi I, Billups CA, Tagen M, Stewart CF, Wu J, Helton K, McCarville MB, Merchant TE, Brennan R, Free TM, Given V, Haik BG, Rodriguez-Galindo C, Wilson MW. Cancer; 2012 Nov 15; 118(22):5663-70. PubMed ID: 22516936 [Abstract] [Full Text] [Related]
18. Intra-arterial chemotherapy is more effective than sequential periocular and intravenous chemotherapy as salvage treatment for relapsed retinoblastoma. Schaiquevich P, Ceciliano A, Millan N, Taich P, Villasante F, Fandino AC, Dominguez J, Chantada GL. Pediatr Blood Cancer; 2013 May 15; 60(5):766-70. PubMed ID: 23024125 [Abstract] [Full Text] [Related]
19. Adverse drug reaction after intravitreal injection of topotecan. Narang S, Sindhu M, Kochhar S, Pandey AK, Goyal P. Indian J Ophthalmol; 2020 Aug 15; 68(8):1648-1649. PubMed ID: 32709802 [No Abstract] [Full Text] [Related]